Your activity: 22 p.v.
your limit has been reached. plz Donate us to allow your ip full access, Email: sshnevis@outlook.com

Conversion disorder in adults: Epidemiology, pathogenesis, and prognosis

Conversion disorder in adults: Epidemiology, pathogenesis, and prognosis
Authors:
Jon Stone, FRCP, PhD
Michael Sharpe, MD
Section Editor:
Joel Dimsdale, MD
Deputy Editor:
David Solomon, MD
Literature review current through: Dec 2022. | This topic last updated: Jun 09, 2022.

INTRODUCTION — Conversion disorder (functional neurologic symptom disorder) is characterized by neurologic symptoms (eg, weakness, abnormal movements, or nonepileptic seizures) that are inconsistent with a neurologic disease, but cause distress and/or impairment [1]. The disorder is common in clinical settings and often has a poor prognosis [2-5].

This topic reviews the epidemiology, pathogenesis, and prognosis of conversion disorder. The terminology, diagnosis, differential diagnosis, clinical features, assessment, and treatment are discussed separately, as are specific subtypes of conversion disorder (psychogenic nonepileptic seizures and functional movement disorders):

(See "Conversion disorder in adults: Terminology, diagnosis, and differential diagnosis".)

(See "Conversion disorder in adults: Clinical features, assessment, and comorbidity".)

(See "Conversion disorder in adults: Treatment".)

(See "Psychogenic nonepileptic seizures: Etiology, clinical features, and diagnosis".)

(See "Functional movement disorders".)

EPIDEMIOLOGY — The prevalence of conversion disorder (functional neurologic symptom disorder) has been more widely studied in clinical settings than in the general population.

General population — A review found that the estimated incidence of conversion disorder across disparate geographical settings was 4 to 12 per 100,000 per year (0.004 to 0.012 percent), and the community prevalence of conversion disorder based upon case registries was 50 per 100,000 per year (0.05 percent) [6].

Clinical settings — The point prevalence of conversion symptoms in clinical settings ranges from 2 to 6 percent:

A prospective study of 157 internal medicine inpatients found that conversion disorder was present in 2 percent [7]

A prospective study of 3781 neurology outpatients found that conversion disorder was present in 6 percent [2]

A retrospective study of 7836 outpatients evaluated by one neurologist found that conversion disorder was present in 4 percent [8]

Sociodemographic correlates — It is not clear if there are any established sociodemographic correlates of conversion disorder, per se. However, a prospective study compared 1144 neurology outpatients with symptoms somewhat or not at all explained by a recognizable neurologic illness (including 209 patients with conversion disorder) with 2637 patients whose symptoms were explained by a neurologic illness [3]. Symptoms not explained by disease were associated with:

Younger age

Female sex

Greater disability, including physical, role, and social functioning

Conversion disorder has been reported in patients of all ages, from early childhood to old age, but is rare before age 10 years [9,10]. A prospective study of 50 patients with conversion disorder found that the mean age of onset was later for psychogenic weakness and movement disorders, compared with psychogenic nonepileptic seizures (39 versus 27 years) [11]. Nevertheless, there have been reports of nonepileptic seizures with onset in an older age group (mean age 61 years, n = 26), amongst whom comorbid disease was prominent [12].

Many studies have found that conversion disorder is more likely to occur in females than males [3,13,14]. However, the preponderance of females may vary by the subtype of the disorder. A pooled analysis of 52 studies that included 2270 patients with conversion disorder found that the proportion of females was less for psychogenic limb weakness than psychogenic nonepileptic seizures (48 versus 74 percent) [11].

ETIOLOGY AND PATHOGENESIS — The etiology and pathogenesis of conversion disorder (functional neurologic symptom disorder) are not clear [15]. However, there are many biological, psychological, and social factors that are more common in patients with functional symptoms than patients with comparable symptoms due to recognizable disease [16]. These factors may predispose patients to conversion disorder or precipitate and/or perpetuate symptoms (table 1).

Premorbid clinical factors — Psychological factors or life events such as trauma, interpersonal conflicts, and recent or old stressors may be associated with onset of conversion disorder [1]. However, psychological factors are not always reported, nor are they specific to conversion disorder [17,18]:

A meta-analysis of 34 retrospective studies examined the history of stressful life events and maltreatment in patients (cases) with conversion disorder (n >1400) and in healthy or patient controls (n >2200) [19]. Stressful life events were more common in patients with conversion disorder than controls (odds ratio 2.8, 95% CI 1.4-6.0). In addition, maltreatment had occurred in more patients than controls:

Emotional neglect (49 versus 20 percent)

Sexual abuse (24 versus 10 percent)

Physical abuse (30 versus 12 percent)

Among the 34 studies, 13 found that some patients with conversion disorder, ranging from 14 to 70 percent, did not have a history of either stressful life events or any type of maltreatment.

In a subsequent retrospective study of 322 patients with motor conversion disorder and 644 psychiatric control patients, the proportion of patients with a history of childhood sexual abuse was similar in both groups (20 and 22 percent), as was the proportion with a history of physical abuse (23 and 22 percent) [14].

Pre-existing disorders and symptoms may predispose patients to developing conversion disorder; in some cases, this process is considered symptom amplification [20]. Compared with controls with recognizable diseases, patients with conversion disorder are more likely to have a history of pre-existing psychiatric disorders (eg, depressive, anxiety, and personality disorders) and other somatic symptoms (eg, pain, fatigue, and cognitive impairment) [11,14,21], or other types of preexisting functional somatic disorders, such as irritable bowel syndrome [22]. In addition, conversion disorder is often preceded by neurologic illnesses (eg, migraine, peripheral nerve pathology, or stroke) that appear to trigger, but do not explain the conversion symptoms [23]. Physical injury may also precede conversion symptoms [24,25].

An excess of symptom modeling (exposure to similar symptoms in others) has been reported in some studies of conversion disorder [26-28] but not others [29-31]. In a negative study, which was relatively large and included 132 patients with functional movement disorders and 148 healthy controls, the proportion of health care workers in each group was comparable (25 and 20 percent) [32].

Perpetuating factors — Conversion symptoms may be perpetuated by beliefs that there is an irreversible neurologic disease, which may create a powerful obstacle to rehabilitation. Clinicians may also make things worse by failing to give a clear explanation and positive diagnosis of the symptoms [33], excessively investigating symptoms [34], prescribing inappropriate drugs and appliances (eg, crutches and wheelchairs when these exceed the patient’s needs) [35], performing unnecessary operations, and misattributing symptoms to recognizable disease or to irrelevant radiologic or laboratory findings (eg, age-related degenerative changes in the vertebrae) [36]. In addition, conversion symptoms may be perpetuated by physical deconditioning, comorbid psychiatric disorders, disability-related financial benefits, and litigation [16,37]. Another potential perpetuating factor is life stress (eg, work or family) that was relieved by onset of the disorder and would probably recur if the patient was to recover from conversion disorder [38].

Hypotheses — Several hypothetical models attempt to explain how conversion symptoms develop; these models are not mutually exclusive.

Cognitive-behavioral models — Multiple overlapping cognitive-behavioral models have been proposed to explain the etiology and pathogenesis of conversion disorder.

One cognitive-behavioral model is based upon findings that processing of perception and behavior mostly occurs outside of awareness, and proposes that conversion symptoms may result from psychological influences at these lower levels of processing [39]. It is suggested that patients with conversion disorder initially encounter (in themselves or others) a stimulus for a particular symptom, such as mild weakness from migraine. This generates a mental representation or memory of paralysis. Excessive anxiety about becoming paralyzed, and/or hypervigilance in looking for evidence (eg, weakness) of paralysis in oneself, may activate the mental representation to the point that it overrides sensory input and distorts awareness and behavior. Selective attentional bias leads patients to persistently focus upon evidence that they are paralyzed and ignore evidence that they are not [40]. Some studies of patients with conversion disorder suggest that their explicit awareness of emotional symptoms, such as anxiety, is low [41,42].

Another cognitive-behavioral model proposes that conversion disorder involves dissociative experiences [6]. Dissociation is subjectively perceived as disconnection from oneself (depersonalization) or the environment (derealization). During dissociation, awareness and integration of thoughts, feelings, memories, and identity is altered, as is integration of somatic experiences and functions, and patients lose functioning of motor control or sensory awareness [43]. Dissociation may occur as a consequence of fatigue, panic attacks [44], physical injuries [24,25,45], recognizable diseases [23,46], iatrogenic triggers such as general anesthesia [44,47], or drug side effects [25]. In this model, the symptom of paralysis or abnormal movement arises during the dissociated state when the patient is “depersonalized” and generally loses feelings of ownership over body movements. Attention paid asymmetrically to this experience, combined with fear of what the symptom might represent (eg, stroke), may intensify and cause more “localized” depersonalization, thus prolonging the symptom. In nonepileptic seizures, prodromal symptoms of panic attacks may become so unbearable that patients respond by losing awareness in an apparent blackout [48-50], with subsequent nonepileptic seizures occurring as a conditioned response to unpleasant thoughts, feelings, and situations, even in the absence of a prodrome.

Some cognitive behavioral models hypothesize that conversion disorder is perpetuated by maladaptive thoughts. Evidence for this hypothesis includes findings that recovery can be impeded by thoughts that conversion symptoms are due to a disease process with a known pathologic basis and beliefs that psychological factors are not involved [9,21,51]. In addition, beliefs that symptoms are caused by recognizable disease and are therefore not reversible appear to be a more powerful predictor of poor prognosis than the number of conversion symptoms or severity of disability [52].

Neurobiologic model — Conversion disorder may involve abnormalities in neural networks of grey matter brain regions rather than a disturbance in one specific structure [6]. These networks are thought to include frontal (orbitofrontal and anterior cingulate cortex) and subcortical (limbic) structures that may be activated by emotional stress, and in turn provide input to inhibitory basal ganglia-thalamocortical circuits that reduce conscious motor or sensory processing [53,54]. In addition, there may be aberrant activity in brain networks that include the inferior parietal lobe/temporoparietal junction and are involved in self-agency, which is the experience that one causes one’s own actions [53,55,56]. One hypothesis is that overly sensitive amygdala responses to fear (ie, abnormal responses to stimuli, including those that are objectively neutral) lead to changes in networks mediating sensory and motor function. In the setting of abnormal self-directed attention (eg, depersonalization), these changes produce sensations or movements that are associated with an abnormal sense of self control and are interpreted as involuntary symptoms of a disease [6,40].

Neuroimaging of patients with conversion disorder has suggested predominantly functional central nervous system changes, but also possibly structural changes. However, it is not known if these differences indicate causal factors, confounding comorbidities, or merely sequelae of the disorder. Functional magnetic resonance imaging comparing patients with conversion disorder (weakness subtype) with healthy controls during recall of traumatic events have found differences in regional brain activity (eg, prefrontal cortex and hippocampus) [57], which correlated with symptom severity [58]. In addition, structural magnetic resonance imaging studies that compared patients with functional movement disorder to healthy controls found evidence of altered brain structure in patients (eg, increased thalamic volume and decreased sensorimotor cortical thickness) [59,60].

One study of patients with conversion disorder found increased levels of basal cortisol [61], whereas another did not [62].

Psychodynamic models — The classic psychodynamic hypothesis, which gives conversion disorder its name, is that patients experience an unconscious conflict that is converted into a somatic symptom [16,63,64]. The symptom serves as a defense against anxiety and distress, which are reduced by the conflict remaining unconscious [43]. In this model, the conversion symptom symbolizes the conflict and may help the patient avoid an overwhelming situation [65]. The hypothesis is difficult to test scientifically, has been hard to apply clinically, and thus has little empirical support [43].

Subsequent psychodynamic hypotheses emphasize abnormal interpersonal relationships that develop in the context of problematic early relationships (eg, poor parenting) or traumatic events [39]. In these models, a new conflict or traumatic event leads to recurrence of previous patterns of abnormal behavior and the development of physical symptoms. The physical symptoms are regarded as a coping response, secondary to emotional dysregulation. As an example, somatic symptoms that lead to contact with clinicians may enable patients to meet dependency needs established earlier in life. Such hypotheses are also hard to test.

Evidence supporting the psychodynamic model includes a retrospective study that assessed patients with conversion disorder (n = 43) and patients with depression (n = 28) for stressors prior to symptom onset, and asked healthy controls (n = 28) about stressors in the prior two years [38]. The stressors/life events were rated for the extent to which symptoms enabled one to escape from an aversive situation or ameliorate the stressor (eg, providing escape from going to work and facing an abusive boss). The incidence of “escape” life events was greater in the month before symptom onset for patients with conversion disorder, than for patients with depression and healthy controls (53 versus 14 and 0 percent).

PROGNOSIS — Prognosis for conversion disorder (functional neurologic symptom disorder) is generally poor. Reviews of observational studies suggest that symptoms persist or worsen in approximately 40 to 66 percent of patients [66]. As an example, a 14 year prospective study of 107 patients with functional limb weakness found that symptoms remitted in 20 percent, improved in 31 percent, persisted in 23 percent, and worsened in 26 percent [67]. Most follow-up studies have also found persistent physical symptoms (eg, fatigue and pain) and impaired quality of life [66].

Among the subtypes of conversion disorder:

Sensory symptoms [68,69] may have a better prognosis than weakness/paralysis [69], dystonia [70], and tremor [1,4].

The prognosis of psychogenic nonepileptic seizures varies, but is often poor. In a systematic review of 25 observational studies, seizure remission occurred in 40 percent or fewer patients [66].

However, prognosis may be better if the disorder is diagnosed early. A prospective study of 54 patients with new onset psychogenic nonepileptic seizures found that within three months of diagnosis, remission had occurred in 50 percent [71].

Baseline predictors of outcome in patients with conversion symptoms vary between studies, and much of what is known comes from studies that included not only patients with conversion disorder, but other somatic symptom and related disorders as well. Across different studies with follow-up ranging from 8 months to 14 years, prognostic factors included the following (table 2) [4,6,23,52,66,67,69,72-76]:

Factors associated with a positive outcome included:

Onset in childhood or adolescence

Early diagnosis

Good response to initial treatment

Comorbid anxiety or depression

Subsequent change in marital status

Good therapeutic alliance with the clinician

Factors associated with a poor outcome included:

Multiple physical symptoms

Longer duration of symptoms

Poor physical functioning

Comorbid personality disorder

Beliefs that symptoms are irreversible and caused by a disease with a known pathologic basis

Illness-related financial benefits

However, these data do not enable clinicians to reliably predict outcome in an individual patient.

SUMMARY

The estimated prevalence of conversion disorder (functional neurologic symptom disorder) in community studies ranges from 0.004 to 0.2 percent, and in clinical settings, from 2 to 6 percent. Sociodemographic correlates of conversion disorder may include younger age, female sex, and greater disability. Onset of conversion disorder rarely occurs prior to age 10 years. (See 'Epidemiology' above.)

The etiology and pathogenesis of conversion disorder are not known. However, many factors have been identified that may predispose patients to conversion disorder or precipitate and/or perpetuate symptoms (table 1). (See 'Etiology and pathogenesis' above.)

Psychological factors or life events such as trauma, interpersonal conflicts, and recent or old stressors may be associated with onset of conversion disorder. However, psychological factors are not always reported, nor are they specific to conversion disorder, and many patients with conversion symptoms may not have identifiable psychological factors. (See 'Premorbid clinical factors' above.)

Pre-existing psychiatric disorders and functional somatic symptoms may predispose patients to developing conversion disorder. In addition, conversion disorder may be triggered by physical injury and neurologic illnesses. (See 'Premorbid clinical factors' above.)

Conversion symptoms may be inadvertently perpetuated by clinicians who fail to give a clear explanation and positive diagnosis of the symptoms, excessively investigate symptoms, prescribe inappropriate drugs and appliances, perform unnecessary operations, and misattribute symptoms to recognizable disease or to irrelevant radiologic or laboratory findings. (See 'Perpetuating factors' above.)

Several hypothetical models attempt to explain how conversion symptoms develop and are not mutually exclusive:

Cognitive-behavioral models emphasize factors such as processing of perception and behavior outside of awareness, selective attentional bias that amplifies minor physiological stimuli and asymmetries, dissociation, and maladaptive thoughts that perpetuate symptoms. (See 'Cognitive-behavioral models' above.)

The neurobiologic model hypothesizes that abnormalities in neural networks of grey matter brain regions involving frontal and subcortical structures are activated by emotional stress, and in turn provide input to inhibitory basal ganglia-thalamocortical circuits that reduce conscious motor or sensory processing. Networks involved in the experience that one causes one’s own actions also appear important. (See 'Neurobiologic model' above.)

The psychodynamic hypothesis is that patients experience an unconscious conflict that is converted into a somatic symptom. The symptom is a defense against anxiety and distress, which are reduced by the conflict remaining unconscious. Subsequent psychodynamic hypotheses emphasize abnormal interpersonal relationships that develop in the context of problematic early relationships or traumatic events. (See 'Psychodynamic models' above.)

Prognosis for conversion disorder is generally poor. Factors associated with positive and poor outcomes are listed in the table (table 2). (See 'Prognosis' above.)

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), American Psychiatric Association, 2013.
  2. Stone J, Carson A, Duncan R, et al. Who is referred to neurology clinics?--the diagnoses made in 3781 new patients. Clin Neurol Neurosurg 2010; 112:747.
  3. Carson A, Stone J, Hibberd C, et al. Disability, distress and unemployment in neurology outpatients with symptoms 'unexplained by organic disease'. J Neurol Neurosurg Psychiatry 2011; 82:810.
  4. Gelauff J, Stone J, Edwards M, Carson A. The prognosis of functional (psychogenic) motor symptoms: a systematic review. J Neurol Neurosurg Psychiatry 2014; 85:220.
  5. Durrant J, Rickards H, Cavanna AE. Prognosis and outcome predictors in psychogenic nonepileptic seizures. Epilepsy Res Treat 2011; 2011:274736.
  6. Carson AJ, Brown R, David AS, et al. Functional (conversion) neurological symptoms: research since the millennium. J Neurol Neurosurg Psychiatry 2012; 83:842.
  7. Fink P, Hansen MS, Oxhøj ML. The prevalence of somatoform disorders among internal medical inpatients. J Psychosom Res 2004; 56:413.
  8. Perkin GD. An analysis of 7836 successive new outpatient referrals. J Neurol Neurosurg Psychiatry 1989; 52:447.
  9. Ewald H, Rogne T, Ewald K, Fink P. Somatization in patients newly admitted to a neurological department. Acta Psychiatr Scand 1994; 89:174.
  10. Weddington WW Jr. Conversion reaction in an 82-year-old man. J Nerv Ment Dis 1979; 167:368.
  11. Stone J, Sharpe M, Binzer M. Motor conversion symptoms and pseudoseizures: a comparison of clinical characteristics. Psychosomatics 2004; 45:492.
  12. Duncan R, Oto M, Martin E, Pelosi A. Late onset psychogenic nonepileptic attacks. Neurology 2006; 66:1644.
  13. Snijders TJ, de Leeuw FE, Klumpers UM, et al. Prevalence and predictors of unexplained neurological symptoms in an academic neurology outpatient clinic--an observational study. J Neurol 2004; 251:66.
  14. O'Connell N, Nicholson TR, Wessely S, David AS. Characteristics of patients with motor functional neurological disorder in a large UK mental health service: a case-control study. Psychol Med 2020; 50:446.
  15. Carson AJ, Zeman A, Stone J, Sharpe MC. Neurology and neurosurgery. In: The American Psychiatric Publishing Textbook of Psychosomatic Medicine: Psychiatric Care of the Medically Ill, Second Edition, Levenson JL (Ed), American Psychiatric Publishing, Inc., Washington, DC 2011. p.759.
  16. Stone J, Carson A, Sharpe M. Functional symptoms in neurology: management. J Neurol Neurosurg Psychiatry 2005; 76 Suppl 1:i13.
  17. Kranick S, Ekanayake V, Martinez V, et al. Psychopathology and psychogenic movement disorders. Mov Disord 2011; 26:1844.
  18. Testa SM, Krauss GL, Lesser RP, Brandt J. Stressful life event appraisal and coping in patients with psychogenic seizures and those with epilepsy. Seizure 2012; 21:282.
  19. Ludwig L, Pasman JA, Nicholson T, et al. Stressful life events and maltreatment in conversion (functional neurological) disorder: systematic review and meta-analysis of case-control studies. Lancet Psychiatry 2018; 5:307.
  20. Rosebush PI, Mazurek MF. Treatment of conversion disorder in the 21st century: have we moved beyond the couch? Curr Treat Options Neurol 2011; 13:255.
  21. Stone J, Warlow C, Sharpe M. The symptom of functional weakness: a controlled study of 107 patients. Brain 2010; 133:1537.
  22. Stone J, Warlow C, Deary I, Sharpe M. Predisposing Risk Factors for Functional Limb Weakness: A Case-Control Study. J Neuropsychiatry Clin Neurosci 2020; 32:50.
  23. Crimlisk HL, Bhatia K, Cope H, et al. Slater revisited: 6 year follow up study of patients with medically unexplained motor symptoms. BMJ 1998; 316:582.
  24. Stone J, Carson A, Aditya H, et al. The role of physical injury in motor and sensory conversion symptoms: a systematic and narrative review. J Psychosom Res 2009; 66:383.
  25. Pareés I, Kojovic M, Pires C, et al. Physical precipitating factors in functional movement disorders. J Neurol Sci 2014; 338:174.
  26. Bautista RE, Gonzales-Salazar W, Ochoa JG. Expanding the theory of symptom modeling in patents with psychogenic nonepileptic seizures. Epilepsy Behav 2008; 13:407.
  27. Hankey GJ, Stewart-Wynne EG. Pseudo-multiple sclerosis: a clinico-epidemiological study. Clin Exp Neurol 1987; 24:11.
  28. Barnert C. Conversion reactions and psychophysiologic disorders: a comparative study. Psychiatry Med 1971; 2:205.
  29. Chabrol H, Peresson G, Clanet M. Lack of specificity of the traditional criteria for conversion disorders. Eur Psychiatry 1995; 10:317.
  30. Nazir FS, Lees KR, Bone I. Clinical features associated with medically unexplained stroke-like symptoms presenting to an acute stroke unit. Eur J Neurol 2005; 12:81.
  31. Roy A. Hysteria. J Psychosom Res 1980; 24:53.
  32. Perry CG, Holmes KG, Gruber-Baldini AL, et al. Are Patients with Psychogenic Movement Disorders More Likely to be Healthcare Workers? Mov Disord Clin Pract 2017; 4:62.
  33. Friedman JH, LaFrance WC Jr. Psychogenic disorders: the need to speak plainly. Arch Neurol 2010; 67:753.
  34. Crimlisk HL, Bhatia KP, Cope H, et al. Patterns of referral in patients with medically unexplained motor symptoms. J Psychosom Res 2000; 49:217.
  35. Davison P, Sharpe M, Wade D, Bass C. "Wheelchair" patients with nonorganic disease: a psychological inquiry. J Psychosom Res 1999; 47:93.
  36. Jensen MC, Brant-Zawadzki MN, Obuchowski N, et al. Magnetic resonance imaging of the lumbar spine in people without back pain. N Engl J Med 1994; 331:69.
  37. Bass C, Murphy M. Somatoform and personality disorders: syndromal comorbidity and overlapping developmental pathways. J Psychosom Res 1995; 39:403.
  38. Nicholson TR, Aybek S, Craig T, et al. Life events and escape in conversion disorder. Psychol Med 2016; 46:2617.
  39. Carson A, Ludwig L, Welch K. Psychologic theories in functional neurologic disorders. In: Handbook of Clinical Neurology: Functional Neurologic Disorders, Elsevier, Cambridge 2016. p.105.
  40. Edwards MJ, Adams RA, Brown H, et al. A Bayesian account of 'hysteria'. Brain 2012; 135:3495.
  41. Dimaro LV, Dawson DL, Roberts NA, et al. Anxiety and avoidance in psychogenic nonepileptic seizures: the role of implicit and explicit anxiety. Epilepsy Behav 2014; 33:77.
  42. Demartini B, Petrochilos P, Ricciardi L, et al. The role of alexithymia in the development of functional motor symptoms (conversion disorder). J Neurol Neurosurg Psychiatry 2014; 85:1132.
  43. Roelofs K, Spinhoven P. Trauma and medically unexplained symptoms towards an integration of cognitive and neuro-biological accounts. Clin Psychol Rev 2007; 27:798.
  44. Stone J, Warlow C, Sharpe M. Functional weakness: clues to mechanism from the nature of onset. J Neurol Neurosurg Psychiatry 2012; 83:67.
  45. Schrag A, Trimble M, Quinn N, Bhatia K. The syndrome of fixed dystonia: an evaluation of 103 patients. Brain 2004; 127:2360.
  46. Pareés I, Saifee TA, Kojovic M, et al. Functional (psychogenic) symptoms in Parkinson's disease. Mov Disord 2013; 28:1622.
  47. Lempert T, Schmidt D. Natural history and outcome of psychogenic seizures: a clinical study in 50 patients. J Neurol 1990; 237:35.
  48. Goldstein LH, Mellers JD. Ictal symptoms of anxiety, avoidance behaviour, and dissociation in patients with dissociative seizures. J Neurol Neurosurg Psychiatry 2006; 77:616.
  49. Stone J, Carson AJ. The unbearable lightheadedness of seizing: wilful submission to dissociative (non-epileptic) seizures. J Neurol Neurosurg Psychiatry 2013; 84:822.
  50. Hendrickson R, Popescu A, Dixit R, et al. Panic attack symptoms differentiate patients with epilepsy from those with psychogenic nonepileptic spells (PNES). Epilepsy Behav 2014; 37:210.
  51. Binzer M, Eisemann M, Kullgren G. Illness behavior in the acute phase of motor disability in neurological disease and in conversion disorder: a comparative study. J Psychosom Res 1998; 44:657.
  52. Sharpe M, Stone J, Hibberd C, et al. Neurology out-patients with symptoms unexplained by disease: illness beliefs and financial benefits predict 1-year outcome. Psychol Med 2010; 40:689.
  53. Maurer CW, LaFaver K, Ameli R, et al. Impaired self-agency in functional movement disorders: A resting-state fMRI study. Neurology 2016; 87:564.
  54. Aybek S, Vuilleumier P. Imaging studies of functional neurologic disorders. In: Handbook of Clinical Neurology: Functional Neurologic Disorders, Elsevier, Cambridge 2016. p.73.
  55. Voon V, Gallea C, Hattori N, et al. The involuntary nature of conversion disorder. Neurology 2010; 74:223.
  56. Baek K, Doñamayor N, Morris LS, et al. Impaired awareness of motor intention in functional neurological disorder: implications for voluntary and functional movement. Psychol Med 2017; 47:1624.
  57. Aybek S, Nicholson TR, Zelaya F, et al. Neural correlates of recall of life events in conversion disorder. JAMA Psychiatry 2014; 71:52.
  58. Diez I, Ortiz-Terán L, Williams B, et al. Corticolimbic fast-tracking: enhanced multimodal integration in functional neurological disorder. J Neurol Neurosurg Psychiatry 2019; 90:929.
  59. Maurer CW, LaFaver K, Limachia GS, et al. Gray matter differences in patients with functional movement disorders. Neurology 2018; 91:e1870.
  60. Bègue I, Adams C, Stone J, Perez DL. Structural alterations in functional neurological disorder and related conditions: a software and hardware problem? Neuroimage Clin 2019; 22:101798.
  61. Apazoglou K, Mazzola V, Wegrzyk J, et al. Biological and perceived stress in motor functional neurological disorders. Psychoneuroendocrinology 2017; 85:142.
  62. Maurer CW, LaFaver K, Ameli R, et al. A biological measure of stress levels in patients with functional movement disorders. Parkinsonism Relat Disord 2015; 21:1072.
  63. Stone J, LaFrance WC Jr, Levenson JL, Sharpe M. Issues for DSM-5: Conversion disorder. Am J Psychiatry 2010; 167:626.
  64. Abbey SE, Wulsin L, Levenson JL. Somatization and somatoform disorders. In: The American Psychiatric Publishing Textbook of Psychosomatic Medicine: Psychiatric Care of the Medically Ill, Second Edition, Levenson JL (Ed), American Psychiatric Publishing, Inc., Washington, DC 2011. p.261.
  65. Maldonado JR. Conversion disorder. In: Gabbard's Treatments of Psychiatric Disorders, Fourth Edition, Gabbard GO (Ed), American Psychiatric Publishing, Inc., Washington, DC 2007. p.595.
  66. Gelauff J, Stone J. Prognosis of functional neurologic disorders. Handb Clin Neurol 2016; 139:523.
  67. Gelauff JM, Carson A, Ludwig L, et al. The prognosis of functional limb weakness: a 14-year case-control study. Brain 2019; 142:2137.
  68. Toth C. Hemisensory syndrome is associated with a low diagnostic yield and a nearly uniform benign prognosis. J Neurol Neurosurg Psychiatry 2003; 74:1113.
  69. Stone J, Sharpe M, Rothwell PM, Warlow CP. The 12 year prognosis of unilateral functional weakness and sensory disturbance. J Neurol Neurosurg Psychiatry 2003; 74:591.
  70. Ibrahim NM, Martino D, van de Warrenburg BP, et al. The prognosis of fixed dystonia: a follow-up study. Parkinsonism Relat Disord 2009; 15:592.
  71. Duncan R, Razvi S, Mulhern S. Newly presenting psychogenic nonepileptic seizures: incidence, population characteristics, and early outcome from a prospective audit of a first seizure clinic. Epilepsy Behav 2011; 20:308.
  72. Jankovic J, Vuong KD, Thomas M. Psychogenic tremor: long-term outcome. CNS Spectr 2006; 11:501.
  73. Carson AJ, Best S, Postma K, et al. The outcome of neurology outpatients with medically unexplained symptoms: a prospective cohort study. J Neurol Neurosurg Psychiatry 2003; 74:897.
  74. Mace CJ, Trimble MR. Ten-year prognosis of conversion disorder. Br J Psychiatry 1996; 169:282.
  75. Couprie W, Wijdicks EF, Rooijmans HG, van Gijn J. Outcome in conversion disorder: a follow up study. J Neurol Neurosurg Psychiatry 1995; 58:750.
  76. Binzer M, Kullgren G. Motor conversion disorder. A prospective 2- to 5-year follow-up study. Psychosomatics 1998; 39:519.
Topic 85764 Version 9.0

References